Sun Pharma is partnering with Art Garfunkel, who is sharing his story of living with moderate-to-severe plaque psoriasis in-depth for the first time publicly.
The Grammy Award-winning artist and Rock and Roll Hall of Fame inductee will be talking about his experience with tildrakizumab-asmn (Ilumya) as part of the “I LUV YA for The Long Haul” campaign.
Giving Psoriasis History a Voice
“With support from my wife, Kim, and a treatment I trust, I am finally ready to give my history with psoriasis a voice,” says Garfunkel. “After struggling for decades, I finally started ILUMYA about two years ago, and experiencing clearer skin has helped me regain my confidence. I am excited to share my story as part of the I LUV YA campaign in the hope that it will encourage others to find the right treatment for them.”
The multi-part video series highlights real-life patient stories, including Garfunkel and how his wife, Kim, provided that support for him.
Tildrakizumab-asmn is a humanized lgG1/k monoclonal antibody designed to selectively bind to the p19 subunit of interleukin-23 (IL-23) and inhibit its interaction with the IL-23 receptor. It is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, in the United States. Tildrakizumab has also been approved for moderate-to-severe plaque psoriasis in Australia and Japan, and under the brand name Ilumetri in Europe, where it is marketed by Almirall.
Campaign Highlights Emotional Impact
The “I LUV YA for The Long Haul” campaign, originally launched in May 2024, highlights the emotional impact psoriasis can have on a patient’s life and how support can help navigate the challenges of managing their condition.
“We are so honored to partner with Art Garfunkel to share his ILUMYA story and to bring greater awareness to the impact psoriasis has beyond the physical symptoms,” says Maureen Shannon, Head of Biologics Marketing at Sun Pharma. “Art’s music has impacted millions and his experience, shared for the first time, is sure to leave a lasting impression.”
To learn more about Art Garfunkel’s experience, visit ILUMYA.com/ILuvYa.
